These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Patient perception of generic antiepileptic drugs in the Midwestern United States.
    Author: Papsdorf TB, Ablah E, Ram S, Sadler T, Liow K.
    Journal: Epilepsy Behav; 2009 Jan; 14(1):150-3. PubMed ID: 18845274.
    Abstract:
    OBJECTIVE: Concerns have been raised about the safety of switching from a branded antiepileptic drug (AED) to a generic AED. The goal of the study described here was to understand patients' experiences with generic AEDs in the Midwestern United States. METHODS: A one-page, six-item survey was mailed to 356 patients to determine patients' awareness of the existence and their usage of generic AEDs. RESULTS: Twenty-eight percent (27.8%) of respondents (N=179) reported breakthrough seizures they believed were a direct result of the switch from a brand to a generic AED, and 33.7% reported side effects due to the switch. Thirty-one percent (31.2%) returned to a brand-name AED as a result. Sixty-nine percent (68.8%) reported being unaware that some pharmacies switch to generic AEDs without a patient's or physician's consent, and 78.7% expressed concern over this. CONCLUSION: A significant percentage of patients reported that generic AEDs were responsible for breakthrough seizures and increased side effects. A significant percentage of patients also reported switching back to a brand-name AED and expressed concern over pharmacies switching to generic AEDs without a patient's or physician's consent.
    [Abstract] [Full Text] [Related] [New Search]